Clinical Research Directory
Browse clinical research sites, groups, and studies.
Capsaicin in Digital Osteoarthritis Versus Control
Sponsor: University Hospital, Clermont-Ferrand
Summary
The objective of this multicentric, randomized controlled double-blind clinical trial is to demonstrate the efficacy of transdermal application of capsaicin in patients with painful digital osteoarthritis with a neuropathic pain component. Participants will receive either a transdermal patch of capsaicin 179 mg (8%) or the control treatment (capsaicin 0.04%). Researchers will compare the intensity of pain in the fingers at day 60 in the capsaicin 8% group versus capsaicin 0.04% (control arm)
Official title: Capsaicin in Digital Osteoarthritis Versus Control : a Randomized Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-03-07
Completion Date
2028-01-01
Last Updated
2025-03-13
Healthy Volunteers
No
Conditions
Interventions
Capsaicin 179 Mg Cutaneous Patch
patch application for 30 minutes on the painful fingers.
Capsaicine low dose 0.04 %
patch application for 30 minutes on the painful fingers. the low-dose patch has a similar appearance to the active patch. It allows you to keep the blind, because it also causes reactions at the capsaicin application site (erythema, burning).
Locations (4)
CHU de Clermont-Ferrand
Clermont-Ferrand, France
HCL Hôpital Edouard Herriot
Lyon, France
AP-HP Hôpital Saint-Antoine
Paris, France
CHU de Saint-Etienne
Saint-Etienne, France